Courtagen Life Sciences Inc-医療機器分野:企業M&A・提携分析

◆英語タイトル:Courtagen Life Sciences Inc - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8012907
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月27日
◆ページ数:31
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Courtagen Life Sciences Inc (Courtagen) is a medical device company that provides neurological treatment solutions. The company’s products include neuro-development panels, lysosomal disorder panels, syndrome panels, comprehensive epilepsy panels, focus epilepsy panels, metabolism test equipments and mitochondrial panels. It also provides drug development services such as target discovery, validation, clinical development, clinical trials, decentralized test development, pre-clinical and clinical trial protocol and companion diagnostic services. Courtagen’s products are used in treatment of mitochondrial disorders, epilepsy and seizure disorders, and neuro-developmental disorders. The company serves patients and physicians. It operates in the US and Bermuda. Courtagen is headquartered in Woburn, Massachusetts, the US.

Courtagen Life Sciences Inc – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Courtagen Life Sciences Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Courtagen Life Sciences Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Courtagen Life Sciences Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Courtagen Life Sciences Inc, Medical Equipment, Deals By Market, 2011 to YTD 2017 8
Courtagen Life Sciences Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Courtagen Life Sciences Inc, Medical Equipment, Deal Details 10
Venture Financing 10
Courtagen Life Sciences Raises USD20 Million in Venture Financing 10
Courtagen Life Sciences Raises USD7.5 Million in Venture Financing 11
Courtagen Life Sciences Raises USD6.3 Million in Venture Financing 12
Courtagen Life Sciences To Raise Funds Through Venture Financing 13
Courtagen Life Sciences Secures US$8 Million In Series B Venture Financing 14
Partnerships 15
Courtagen Life Sciences Enters Into Licensing Agreement With Scienion For sciFlexArrayer Technology 15
Courtagen Life Sciences Enter into Distribution Agreement with Pronto Diagnostics for Next Generation Sequencing Tests 16
Courtagen Life Sciences Enters Into An Agreement With SimulConsult For Genome-Phenome Analyzer 17
Courtagen Life Sciences Enters Into Agreement With Raptor Pharma For Genetic Testing 18
Courtagen Life Sciences Enters Into Co-Development Agreement With Tetracore 19
MedTrust Online Enters Into Co-Development Agreement With Avantra Biosciences 20
Courtagen Life Sciences Inc – Key Competitors 21
Courtagen Life Sciences Inc – Key Employees 22
Courtagen Life Sciences Inc – Locations And Subsidiaries 23
Head Office 23
Other Locations & Subsidiaries 23
Recent Developments 24
Strategy And Business Planning 24
Jul 18, 2017: Courtagen Life Sciences Shifts Focus to its Medicinal Cannabis Genetics and Testing Business 24
Corporate Communications 25
May 03, 2016: Courtagen Life Sciences Adds Pediatric Neurologist, Ngoc Minh Le, M.D., to the Company’s Clinical Team 25
Legal and Regulatory 26
Jan 21, 2016: Courtagen Life Sciences Receives New York State Clinical Laboratory Approval 26
Product News 27
Mar 01, 2017: Courtagen Continues Menu Expansion with Launch of New Spotlight Gene Tests for Neuromuscular Disorders 27
Feb 03, 2017: Courtagen Launches 17 New Spotlight Gene Tests for Neurology and Endocrinology 28
Aug 25, 2016: U.S. Patent Granted for Courtagen’s Novel DREAM PCR Decontamination Technology 29
Other Significant Developments 30
Dec 02, 2016: Courtagen Life Sciences Partners with Certainty Health to Pioneer the First Collaborative Ecosystem for Neurological Disorders 30
Appendix 31
Methodology 31
About GlobalData 31
Contact Us 31
Disclaimer 31

List of Tables
Courtagen Life Sciences Inc, Medical Equipment, Key Facts 2
Courtagen Life Sciences Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
Courtagen Life Sciences Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Courtagen Life Sciences Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Courtagen Life Sciences Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Courtagen Life Sciences Inc, Deals By Market, 2011 to YTD 2017 8
Courtagen Life Sciences Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Courtagen Life Sciences Raises USD20 Million in Venture Financing 10
Courtagen Life Sciences Raises USD7.5 Million in Venture Financing 11
Courtagen Life Sciences Raises USD6.3 Million in Venture Financing 12
Courtagen Life Sciences To Raise Funds Through Venture Financing 13
Courtagen Life Sciences Secures US$8 Million In Series B Venture Financing 14
Courtagen Life Sciences Enters Into Licensing Agreement With Scienion For sciFlexArrayer Technology 15
Courtagen Life Sciences Enter into Distribution Agreement with Pronto Diagnostics for Next Generation Sequencing Tests 16
Courtagen Life Sciences Enters Into An Agreement With SimulConsult For Genome-Phenome Analyzer 17
Courtagen Life Sciences Enters Into Agreement With Raptor Pharma For Genetic Testing 18
Courtagen Life Sciences Enters Into Co-Development Agreement With Tetracore 19
MedTrust Online Enters Into Co-Development Agreement With Avantra Biosciences 20
Courtagen Life Sciences Inc, Key Competitors 21
Courtagen Life Sciences Inc, Key Employees 22
Courtagen Life Sciences Inc, Subsidiaries 23

★海外企業調査レポート[Courtagen Life Sciences Inc-医療機器分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Alfresa Holdings Corporation:企業の戦略・SWOT・財務情報
    Alfresa Holdings Corporation - Strategy, SWOT and Corporate Finance Report Summary Alfresa Holdings Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Grant Thornton International Ltd:企業の戦略的SWOT分析
    Grant Thornton International Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pr …
  • Koch Enterprises, Inc.:企業の戦略的SWOT分析
    Koch Enterprises, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Lietuvos Energija UAB:電力:M&Aディール及び事業提携情報
    Summary Lietuvos Energija UAB (Lietuvos Energija) is a state-owned utility. The utility’s activities include power and heat distribution and supply; natural gas trade and distribution; construction and maintenance of power plants and grid; development of energy infrastructure and green energy; and d …
  • Hydro Ottawa Holding Inc:企業の戦略的SWOT分析
    Hydro Ottawa Holding Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • Community Health Systems Inc (CYH)-製薬・医療分野:企業M&A・提携分析
    Summary Community Health Systems Inc. (CHS) is an operator of general acute care hospitals and outpatient facilities in communities. The company’s services include general acute care services, emergency room services, general and specialty surgery, critical care, internal medicine, obstetrics and di …
  • Korn/Ferry International:企業の戦略・SWOT・財務情報
    Korn/Ferry International - Strategy, SWOT and Corporate Finance Report Summary Korn/Ferry International - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Enusa Industrias Avanzadas, S.A., S.M.E:企業の戦略的SWOT分析
    Enusa Industrias Avanzadas, S.A., S.M.E - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and m …
  • Aiphone Co Ltd (6718):企業の財務・戦略的SWOT分析
    Aiphone Co Ltd (6718) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Cheung Kong Infrastructure Holdings Ltd:企業の戦略・SWOT・財務情報
    Cheung Kong Infrastructure Holdings Ltd - Strategy, SWOT and Corporate Finance Report Summary Cheung Kong Infrastructure Holdings Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT a …
  • SecureWorks Corp (SCWX):企業の財務・戦略的SWOT分析
    SecureWorks Corp (SCWX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Obalon Therapeutics Inc (OBLN):製薬・医療:M&Aディール及び事業提携情報
    Summary Obalon Therapeutics Inc (Obalon Therapeutics) is a manufacturer of medical devices and equipment. The company offers development and commercializing medical devices to treat obese and overweight people by facilitating weight loss. It also researches, designs, produces, and sells medical gast …
  • Eckert & Ziegler Strahlen- und Medizintechnik AG (EUZ):企業の財務・戦略的SWOT分析
    Summary Eckert & Ziegler Strahlen- und Medizintechnik AG (Eckert & Ziegler) is a medical device company that offers isotope technology products. The company offers radiation therapy, isotope and radio-pharma products. It provides radiation therapy products for Brachytherapy, a minimally invasive pro …
  • Broadridge Financial Solutions, Inc. (BR):企業の財務・戦略的SWOT分析
    Broadridge Financial Solutions, Inc. (BR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strength …
  • Siemens Medical Solutions USA Inc:医療機器:M&Aディール及び事業提携情報
    Summary Siemens Medical Solutions USA Inc (Siemens Medical USA), a subsidiary of Siemens Healthcare GmbH is a medical device company that designs, develops, manufactures and distributes medical devices and technologies for diagnostic markets. The company offers products in the areas of medical imagi …
  • Occidental Chemical Corporation:企業の戦略的SWOT分析
    Occidental Chemical Corporation - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pro …
  • ReWalk Robotics Ltd (RWLK):医療機器:M&Aディール及び事業提携情報
    Summary ReWalk Robotics Ltd (ReWalk) is a medical device company that designs, develops and commercializes exoskeletons. The company provides walk restoration devices for people with lower limb disabilities to stand and walk once again. Its products include ReWalk personal system and ReWalk rehabili …
  • CK Hutchison Holdings Ltd:企業のM&A・事業提携・投資動向
    CK Hutchison Holdings Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's CK Hutchison Holdings Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisi …
  • Regional Express Holdings Limited:企業の戦略・SWOT・財務情報
    Regional Express Holdings Limited - Strategy, SWOT and Corporate Finance Report Summary Regional Express Holdings Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Rhizen Pharmaceuticals SA-製薬・医療分野:企業M&A・提携分析
    Summary Rhizen Pharmaceuticals SA (Rhizen Pharma), a subsidiary of Alembic Pharmaceuticals Ltd is a biopharmaceutical company that discovers and develops small molecule drugs. The company’s research products includes c-Met inhibitors, selective P13K inhibitors, CRAC channel inhibitors and GPR 119 ag …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆